Citations

Showing 10 of 108083 citations.

Effect of a Global Pandemic on Adult and Pediatric Cochlear Implantation across the United States
Marinelli, John P. , Nassiri, Ashley M. , Lohse, Christine M. , Driscoll, Colin L. W., Neff, Brian A., Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | January 10, 2023 | Volume: 44 | Issue: 2 | Pages: 148-152

10.1097/mao.0000000000003778 | PMID 36624592 Get It

Objective To characterize the effect of the COVID-19 pandemic on national cochlear implantation utilization by age using inclusive cochlear implantation data from two manufacturers between 2015 and 2020. Study Design Analysis of prospectively registered consecutive patient data from two major cochlear implant (CI) manufacturers in the United States. Patients Children or adults who received CIs. Interventions Cochlear implantation. Main Outcome Measures Annual implantation utilization by age. Results A total of 46,804 patients received CIs from the two participating manufacturers between 2015 and 2020. The annual number of implant recipients increased significantly during the first 5 years of the study period for both children and adults, from a total of 6,203 in 2015 to 9,213 in 2019 (p < 0.001). During 2020, there was a 13.1% drop in national cochlear implantation utilization across all ages compared with 2019, including a drop of 2.2% for those ≤3 years old, 3.8% for those 4–17 years old, 10.1% for those 18–64 years old, 16.6% for those 65–79 years old, and 22.5% for those ≥80 years old. In a multivariable linear regression model, the percent drop in CIs differed significantly by age-group (p = 0.005). Conclusions Especially in light of the prepandemic projected CI counts for 2020, the COVID-19 pandemic reduced national cochlear implantation utilization by over 15% among Medicare-aged patients and by almost 25% among those ≥80 years old, resulting in more than a 3-year setback in total annual CIs. Children were less affected, with those ≤3 years old experiencing minimal interruption during 2020.
Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation
Schiffer, Lina , Kempegowda, Punith , Sitch, Alice , Shaheen, Fozia , Ebbehøj, Andreas , Singh, Sumitabh , McTaggart, Malcom P, Prete, Alessandro , Hawley, James , Keevil, Brian , Taylor, Angela E. , Arlt, Wiebke , Sitch, Alice J , Ebbehøj, Andreas Ladefoged , Prete, Alessandro , Bancos, Irina , Arlt, Wiebke , Taylor, Angela E , Adaway, Jo , McTaggart, Malcolm P. , O'Reilly, Michael W , Bancos, Irina

Mayo Clinic

European Journal of Endocrinology | January 10, 2023 | Volume: 188 | Issue: 1 | Pages: 86-100

10.1093/ejendo/lvac017 | PMID 36651154 Get It

Abstract Objective 11-oxygenated androgens significantly contribute to the circulating androgen pool. Understanding the physiological variation of 11-oxygenated androgens and their determinants is essential for clinical interpretation, for example, in androgen excess conditions. We quantified classic and 11-oxygenated androgens in serum and saliva across the adult age and body mass index (BMI) range, also analyzing diurnal and menstrual cycle-dependent variation. Design Cross-sectional. Morning serum samples were collected from 290 healthy volunteers (125 men, 22-95 years; 165 women, 21-91 years). Morning saliva samples were collected by a sub-group (51 women and 32 men). Diurnal saliva profiles were collected by 13 men. Twelve women collected diurnal saliva profiles and morning saliva samples on 7 consecutive days during both follicular and luteal menstrual cycle phases. Methods Serum and salivary steroids were quantified by liquid chromatography–tandem mass spectrometry profiling assays. Results Serum classic androgens decreased with age-adjusted BMI, for example, %change kg/m2 for 5α-dihydrotestosterone: men −5.54% (95% confidence interval (CI) −8.10 to −2.98) and women −1.62% (95%CI −3.16 to −0.08). By contrast, 11-oxygenated androgens increased with BMI, for example, %change kg/m2 for 11-ketotestosterone: men 3.05% (95%CI 0.08-6.03) and women 1.68% (95%CI −0.44 to 3.79). Conversely, classic androgens decreased with age in both men and women, while 11-oxygenated androgens did not. Salivary androgens showed a diurnal pattern in men and in the follicular phase in women; in the luteal phase, only 11-oxygenated androgens showed diurnal variation. Conclusions Classic androgens decrease while active 11-oxygenated androgens increase with increasing BMI, pointing toward the importance of adipose tissue mass for the activation of 11-oxygenated androgens. Classic but not 11-oxygenated androgens decline with age.
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM , BRCA1 , BRCA2 ,
Yadav, Siddhartha , Boddicker, Nicholas , Na, Jie , Polley, Eric C. , Hart, Steven N. , Larson, Nicole L. , Holtegaard, Susan, Huang, Huaizhi , Dunn, Carolyn, Patel, Alpa V. , Martínez, Elena, Haiman, Christopher A. , Chen, Fei , Ruddy, Kathryn J. , John, Esther M. , Kurian, Allison W. , Taylor, Jack A. , Zirpoli, Gary , Goldgar, David E. , Weitzel, Jeffrey N. , Nathanson, Katherine L. , Chen, Chen , Lumby, Carolyn A. , Boddicker, Nicholas J , Hu, Chunling , Hart, Steven N , Gnanaolivu, Rohan D., Larson, Nicole , Dunn, Carolyn A, Teras, Lauren R , Neuhausen, Susan L. , Martı́nez, Marı́a Elena , Haiman, Christopher A , Chen, Fei , Ruddy, Kathryn J , John, Esther M , Kurian, Allison W , Sandler, Dale P , O'Brien, Katie M , Taylor, Jack A , Anton-Culver, Hoda , Ziogas, Argyrios , Zirpoli, Gary , Goldgar, David E , Palmer, Julie R , Domchek, Susan M , Weitzel, Jeffrey N , Nathanson, Katherine L , Kraft, Peter , Couch, Fergus J. , Chen, C , Yadav, Siddhartha , Polley, Eric C , Na, Jie , Huang, Huaizhi , Lumby, Carolyn A , Hu, Chunling , Gnanaolivu, Rohan , Teras, Lauren R. , Lacey, James V. , Olson, Janet E. , Sandler, Dale P. , O’Brien, Katie M. , Weinberg, Clarice R. , Anton‐Culver, Hoda , Ziogas, Argyrios , Palmer, Julie R. , Domchek, Susan M. , Kraft, Peter , Couch, Fergus J.

Mayo Clinic

Journal of Clinical Oncology | January 9, 2023 | Volume: 41 | Issue: 9 | Pages: 1703-1713

10.1200/jco.22.01239 | PMID 36623243 Get It

PURPOSE To estimate the risk of contralateral breast cancer (CBC) among women with germline pathogenic variants (PVs) in ATM, BRCA1, BRCA2, CHEK2, and PALB2. METHODS The study population included 15,104 prospectively followed women within the CARRIERS study treated with ipsilateral surgery for invasive breast cancer. The risk of CBC was estimated for PV carriers in each gene compared with women without PVs in a multivariate proportional hazard regression analysis accounting for the competing risk of death and adjusting for patient and tumor characteristics. The primary analyses focused on the overall cohort and on women from the general population. Secondary analyses examined associations by race/ethnicity, age at primary breast cancer diagnosis, menopausal status, and tumor estrogen receptor (ER) status. RESULTS Germline BRCA1, BRCA2, and CHEK2 PV carriers with breast cancer were at significantly elevated risk (hazard ratio > 1.9) of CBC, whereas only the PALB2 PV carriers with ER-negative breast cancer had elevated risks (hazard ratio, 2.9). By contrast, ATM PV carriers did not have significantly increased CBC risks. African American PV carriers had similarly elevated risks of CBC as non-Hispanic White PV carriers. Among premenopausal women, the 10-year cumulative incidence of CBC was estimated to be 33% for BRCA1, 27% for BRCA2, and 13% for CHEK2 PV carriers with breast cancer and 35% for PALB2 PV carriers with ER-negative breast cancer. The 10-year cumulative incidence of CBC among postmenopausal PV carriers was 12% for BRCA1, 9% for BRCA2, and 4% for CHEK2. CONCLUSION Women diagnosed with breast cancer and known to carry germline PVs in BRCA1, BRCA2, CHEK2, or PALB2 are at substantially increased risk of CBC and may benefit from enhanced surveillance and risk reduction strategies.
Bad players in AL amyloidosis in the current era of treatment
Kreiniz, Natalia , Gertz, Morie A. , Gertz, Morie A

Mayo Clinic

Expert Review of Hematology | January 9, 2023 | Volume: 16 | Issue: 1 | Pages: 33-49

10.1080/17474086.2023.2166924 | PMID 36620914 Get It

Ursodeoxycholic Acid Treatment–Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis
Veer, Rozanne C. de , Hooff, Maria C. van , Thorburn, Douglas , Janssen, Harry L.A. , Nevens, Frederik , Lindor, Keith D. , Floreani, Annarosa , Ponsioen, Cyriel Y. , Mayo, Marlyn J. , Mason, Andrew L. , Goet, Jorn , Bruns, Tony , Verhelst, Xavier , Meer, Adriaan J. van der, Group, on behalf of the Global PBC Study, Bruns, Tony , Mason, Andrew , Verhelst, Xavier , Corpechot, Christophe , Invernizzi, Pietro , Lammers, Willem J. , Battezzati, Pier Maria , Parés, Albert , Kowdley, Kris V. , Trivedi, Palak Jitendrakumar , Hirschfield, Gideon M. , Dalekos, George Ν. , Gatselis, Nikolaos , Hansen, Bettina E. , Harms, Maren H. , Meer, Adriaan J. van der, Group, on behalf of the Global PBC Study

Mayo Clinic

American Journal of Gastroenterology | January 9, 2023 | Volume: 118 | Issue: 7 | Pages: 1196-1203

10.14309/ajg.0000000000002128 | PMID 36621963 Get It

INTRODUCTION: Treatment of primary biliary cholangitis (PBC) can improve the GLOBE score. We aimed to assess the association between changes in the GLOBE score (ΔGLOBE) and liver transplantation (LT)–free survival in patients with PBC who were treated with ursodeoxycholic acid (UDCA). METHODS: Among UDCA-treated patients within the Global PBC cohort, the association between ΔGLOBE (ΔGLOBE 0–1 : during the first year of UDCA, ΔGLOBE 1–2 : during the second year) and the risk of LT or death was assessed through Cox regression analyses. RESULTS: Overall, 3,775 UDCA-treated patients were included; 3,424 (90.7%) were female, the median age was 54.0 (interquartile range [IQR] 45.9–62.4) years, and the median baseline GLOBE score was 0.25 (IQR −0.47 to 0.96). During a median follow-up of 7.2 (IQR 3.7–11.5) years, 730 patients reached the combined end point of LT or death. The median ΔGLOBE 0–1 was −0.27 (IQR −0.56 to 0.02). Cox regression analyses, adjusted for pretreatment GLOBE score and ΔGLOBE 0–1 2 , showed that ΔGLOBE was associated with LT or death (adjusted hazard ratio 2.28, 95% confidence interval 1.81–2.87, P < 0.001). The interaction between baseline GLOBE score and ΔGLOBE 0–1 was not statistically significant ( P = 0.296). The ΔGLOBE 1–2 was associated with LT or death (adjusted hazard ratio 2.19, 95% confidence interval 1.67–2.86, P < 0.001), independently from the baseline GLOBE score and the change in GLOBE score during the first year of UDCA. DISCUSSION: UDCA-induced changes in the GLOBE score were significantly associated with LT-free survival in patients with PBC. While the relative risk reduction of LT or death was stable, the absolute risk reduction was heavily dependent on the baseline prognosis of the patient.
Super-Refractory Status Epilepticus During Blinatumomab Initiation for B-Cell Acute Lymphoblastic Leukemia
Rao, Chethan K. , Kamoroff, Samuel, Zorrilla, Julian, Joyce, Michael , Galán, Fernando , Kamoroff, Samuel , Galan, Fernando N , Kamoroff, Sam , Joyce, Michael

Mayo Clinic

Immunotherapy | January 9, 2023 | Volume: 14 | Issue: 18 | Pages: 1437-1442

10.2217/imt-2021-0344 | PMID 36617960 Get It

Abstract B072: Influence of access to care on cancer diagnoses in the CaPTC Prostate Cancer Familial Cohort Study of African Ancestry in Nigeria, Cameroon, and the United States
Otero, Jessica, Jibrin, Paul, Sowumi, Anthonia, Nkegoum, Blaise , Oladoyinbo, Catherine, Salako, Abdulkadir Ayo, Omonisi, Abidemi , Bassey, Iya Eze , Adenji, Kayode, Asura, Nggada Haruna, Kukoyi, Oluwole, Fathi, Parisa , Enuka, Ruth, Toye, Oluwaseyi, Crook, Jennifer , Odedina, Folakemi T., Iweala, Emeka Eze Joshua , Popoola, Ademola , Faruk, Mohammed , Fatiregun, Omolara , Okoye, Ifeoma Joy , Kaninjing, Ernest , Enuka, Ruth, Toye, Oluwaseyi

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 9, 2023 | Volume: 32 | Issue: 1_Supplement | Pages: B072-B072

10.1158/1538-7755.disp22-b072 Get It

Abstract BACKGROUND Black populations are disproportionately affected by prostate cancer globally. The leading countries in prostate cancer mortality are found in Africa and the Caribbean. This data is being presented as part of the Prostate Cancer Transatlantic Consortium (CaPTC) Prostate Cancer Familial Cohort Study of African Ancestry study with the purpose of identifying the various factors that influence prostate cancer risk factors. Access to care, a known cancer risk factor, not only affects a person’s ability to receive treatment but to receive accurate health information, preventative care, diagnoses, and more. Researching exactly how different social determinants, such as this one, affect cancer risk factors for specific populations is imperative to reducing their cancer burden. METHODS: This ten-year prospective study started in 2017 and has been conducted in Nigeria, Cameroon, and the United States. Participants have been recruited in clinics and different community settings. Upon consent, participants were asked to complete a validated survey with a unique identifier on epidemiological, behavioral, clinical, and anthropometric variables. They were then asked to provide a saliva sample that was also given a unique identifier. Associations of characteristics from the survey were evaluated using logistic regression models. Others were tested for statistical significance using a Chi-Squared test. RESULTS: A total of 803 responses are included in this dataset. Of these participants, 9.6% were from Cameroon, 82.6% from Nigeria, and 7.3% from the United States. More than half of the participants (54.9%) shared they did not have healthcare coverage. In addition, a chi-squared test showed 10.2% in the United States, 13.9% in Nigeria and 35.1% in Cameroon were unable to see a physician due to cost with a p-value of less than .001 indicating statistical significance. While participants in the United States did not report any cancer diagnoses, logistical regression found a significant inverse relationship between health literacy and increased risk of a cancer diagnosis. CONCLUSION Research shows a relationship between health access factors and cancer risk factors, but little research is done for specific populations. Further research should be done to measure the exact impact access to care has on cancer diagnoses for specific communities. It is very important that health equity researchers assess exactly how these factors affect the specific populations they work with to tailor evidence-based interventions to their needs. Citation Format: Jessica Otero, Emeka Iweala, Ademola Popoola, Paul Jibrin, Mohammed Faruk, Anthonia Sowumi, Omolara Fatiregun, Nkegoum Blaise, Catherine Oladoyinbo, Ifeoma Okoye, Abdulkadir Ayo Salako, Abidemi Omonisi, Iya Eze Bassey, Kayode Adenji, Nggada Haruna Asura, Ernest Kaninjing, Oluwole Kukoyi, Parisa Fathi, Ruth Enuka, Oluwaseyi Toye, Jennifer Crook, Folakemi Odedina. Influence of access to care on cancer diagnoses in the CaPTC Prostate Cancer Familial Cohort Study of African Ancestry in Nigeria, Cameroon, and the United States [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr B072.
Abstract B083: Black men's willingness to participate in prostate cancer clinical trials: Demystifying clinical trial activities through the MiCaP Research Digest study
Fathi, Parisa , Walsh-Childers, Kim , Odedina, Folakemi T.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 9, 2023 | Volume: 32 | Issue: 1_Supplement | Pages: B083-B083

10.1158/1538-7755.disp22-b083 Get It

Abstract Introduction: According to the American Cancer Society’s Cancer Control Blueprint, one of the reasons for the underrepresentation of minorities in clinical trials (CTs) is lack of engagement and effective recruitment of minoritized populations. This has inadvertently impacted the willingness of minorities to participate in CTs. The Minority Prostate Cancer (MiCaP) Research Digest is a dissemination platform that shares the latest scientific discoveries about prostate cancer (CaP) research, targeting Black men (BM), a population that is historically difficult to enroll in CTs. This study explored the willingness of BM in participating in various CTs. Methods: BM between the ages of 35 and 70 years who reside in the U.S. and have internet access were invited to enroll in the MiCaP study. Participants were randomly assigned to an intervention group exposed to the research digest (video and educational materials about a research study and CT) and a control group. Enrolled participants completed baseline and follow-up surveys with questions focused on willingness to participate in CTs. Descriptive statistics was employed to compare the groups on baseline and follow-up responses. Results: Majority of participants were US-born BM (93.06%), single (49.52%), attended/graduated college (35.65%), between 60 and 69 years (25.58%), had full-time employment (52.07%), had household income between 20,000 and 39,999 (21.66%) and live in urban setting (75.46%). However, only about 35% had read or heard about clinical trials within the last year. Only 14% reported they had been asked to participate in CTs within the last year, and more than 70% indicated that they would participate asked. Participants were asked to state the type of CT activity they would be willing to participate in within the next year. For the intervention group, the percentage of participants willing to participate in CTs increased for almost all activities (except major surgery). There were also slight increases in the Control group with the largest increase in being on a limited or restricted diet (+8.53%). Over 70% of all participants were willing to participate in trials that involved giving blood, doing exercises, being interviewed in person or by phone, completing a survey, being on limited diets and taking pills. Interestingly, undergoing minor surgery had the largest increase relative to CT participation (+6.9%). Participants were also asked to express their perceived behavioral control (BC) by indicating the ease of participating in CTs and finding information about CaP. As expected, the percentage of intervention group participants with high BC (selected very easy or easy) increased from baseline to follow up. Conclusion: With appropriate engagement and culturally responsive educational materials, BM are receptive to participating in a variety of CT activities. It is however important to note that the Black population is ethnically and culturally diverse, and thus the engagement and education should be tailored based on the men’s needs, ethnicity, and cultural views. Citation Format: Parisa Fathi, Kim Walsh-Childers, Folakemi Odedina. Black men's willingness to participate in prostate cancer clinical trials: Demystifying clinical trial activities through the MiCaP Research Digest study [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr B083.
Abstract B073: Quality of life indicators including mental health factors in CaPTC prostate cancer familial cohort study of men of African Ancestry in Nigeria, Cameroon, and United States
Otero, Jessica, Jibrin, Paul, Sowumi, Anthonia, Nkegoum, Blaise , Oladoyinbo, Catherine, Salako, Abdulkadir Ayo, Omonisi, Abidemi , Bassey, Iya Eze , Adenji, Kayode, Asura, Nggada Haruna, Kukoyi, Oluwole, Fathi, Parisa , Enuka, Ruth, Toye, Oluwaseyi, Crook, Jennifer , Odedina, Folakemi T., Iweala, Emeka Eze Joshua , Popoola, Ademola , Faruk, Mohammed , Fatiregun, Omolara , Okoye, Ifeoma Joy , Kaninjing, Ernest , Enuka, Ruth, Toye, Oluwaseyi

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 9, 2023 | Volume: 32 | Issue: 1_Supplement | Pages: B073-B073

10.1158/1538-7755.disp22-b073 Get It

Abstract INTRODUCTION The Prostate Cancer Transatlantic Consortium (CaPTC) has the goal of better understanding the burden of prostate cancer among Black men of West African descent. While prostate cancer disproportionately affects Blacks around the world, little research is done to understand what mental health and social support play a role in prostate cancer risk factors. The purpose of this 10-year longitudinal study is to establish a cohort of U.S.-born Black men, West African-born Black men who reside in the U.S, and West African Black men in Africa who would be prospectively and longitudinally followed to better understand the cause of prostate cancer and how different factors might influence it. METHODS Study staff partnered with community-based organizations, events, and stakeholders to engage with the priority population. Snowball sampling was also used for recruitment. All participants were made aware of the longitudinal nature of the study and that they would be contacted every two years for follow-up. Informed consent was done in community settings electronically and on paper. Once consent was received, participants completed the survey with a unique identifier and filled out a Cohort Contact sheet. They were given the option to complete this on their own or with the help of the study staff. Study Staff would then measure participants’ weight, height, and waistline, to be recorded on the survey form. After this, participant saliva was collected and tracked with the unique identifier. All collected data was stored on RedCap and a Chi-squared test was utilized to identify statistical significance. RESULTS 803 participants are included in this data with 77 in Cameroon, 663 in Nigeria, and 59 in the United States. When asked about emotional support, 13.6% (US) 11.8% (Nigeria), and 14.3% (Cameroon) indicated never or rarely having emotional support. 5.8% of those in the United States, 5.6% of those in Nigeria, and 7.8% of those in Cameroon felt dissatisfied or very dissatisfied with their lives. The p-value for both was found to be &lt;0.001, therefore, suggesting statistical significance. On the other hand, participants described having an average of 6.53 (US), 9.4 (Nigeria), and 8.26% (Cameroon) days where their mental health was not good. However, this was statistically insignificant with a p-value of .95. CONCLUSION Mental health issues have been on the rise since the COVID-19 pandemic. While many people of color have stigmatized needing mental health help, it is important to find ways to overcome this barrier in assessing mental health and social support needs. Future research should continue to ask mental health and social support questions in order to assess their role in prostate cancer risk factors. Citation Format: Jessica Otero, Emeka Iweala, Ademola Popoola, Paul Jibrin, Mohammed Faruk, Anthonia Sowumi, Omolara Fatiregun, Nkegoum Blaise, Catherine Oladoyinbo, Ifeoma Okoye, Abdulkadir Ayo Salako, Abidemi Omonisi, Iya Eze Bassey, Kayode Adenji, Nggada Haruna Asura, Ernest Kaninjing, Oluwole Kukoyi, Parisa Fathi, Ruth Enuka, Oluwaseyi Toye, Jennifer Crook, Folakemi Odedina. Quality of life indicators including mental health factors in CaPTC prostate cancer familial cohort study of men of African Ancestry in Nigeria, Cameroon, and United States [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr B073.